Gemalto, the world leader in digital security, is supplying Telefónica Group, one of the largest telecommunications companies in the world, with an On-Demand Connectivity cloud service that enables ‘out-of-the-box’ mobile connectivity for consumer products such as connected PCs and wearables. As a result, Telefónica can offer its customers seamless over-the-air management of a mobile subscription for any device fitted with an embedded SIM (eSIM). End users will be able to directly purchase, modify or update their existing subscription plan, without the need to fit or change a SIM.
The new Gemalto cloud service is available to all Telefónica Group mobile operators, extending across 17 different countries. Fully compliant with the latest GSMA Remote SIM Provisioning specifications, Gemalto’s solution aims at extending convenient mobile connectivity to millions of consumer devices and bringing new services to users – whether for health monitoring, asset-tracking, tablet and PC connectivity on the move, or fitness activities enhanced by a smartwatch without the need to carry a smartphone.
When combined with the cloud-based on-demand connectivity service the eSIM saves space for miniaturized consumer devices, streamlines manufacturing and logistics while providing high levels of security. Gemalto’s solution opens new markets for mobile network operators, as well as opportunities for innovation, differentiation and new consumer services for OEMs.
Open and Secure Synopsys Autopilot Platform Accelerates Engineering Productivity, Improves Design Quality, and Achieves Faster…
Acquisition brings leading AI model research expertise to AMD, helping to shape future AI infrastructure…
Following its merger with Bank Leumi USA, the expansion of its activities with technology companies…
Infineon and Eaton are partnering to drive solid-state transformer (SST) technology The collaboration addresses demand…
The future of work belongs to people and AI agents. Island built the control plane…
Financing builds on FDA clearances, growing clinical evidence and commercial traction to advance the UltraSight…